Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #1

    Amazon EC2 Choices?

    I'm curious as to how many folks out there have used the Amazon EC2 compute services to run 2nd gen sequencing analyses "in the cloud" and particularly which particular compute offerings you chose.

    For those who haven't looked at this, Amazon has a variety of compute schemes which can be rented by the hour which differ in the amount of RAM, local storage & compute power. I'm trying to get a handle on how to map these onto real world compute problems -- working with vertebrate genomes using BWA, Bowtie, BFAST, TopHat, dindel, etc.

    A quick table I've assembled from Amazon's own specs;
    Code:
    Family	        Name	                        Gb RAM	EC2	Gb Disk	Bits	I/O
    Standard	Large		7.500	4.0	850	64	high
    Standard	Extra Large	15.000	8.0	1,690	64	high
    High-Memory	Extra Large	17.100	6.5	   420	64	moderate
    High-Memory	Double Extra Large	34.200	13.0	  850	64	high
    High-Memory	Quadruple Extra Large	68.400	26.0	1,690	64	high
    High-CPU	Extra Large		7.000	20.0	1,690	64	high
    Cluster Compute	Quadruple Extra Large	23.000	33.5	1,690	64	very high
    I've left out the "Micro" instance as I'm still trying to figure out what it does, and have also left out the 32-bit options.

    EC2 here is their attempt to estimate performance; apparently 1 EC2 is equivalent to a 1.7Ghz Xenon processor with generally 2 cores per processor.

    Pricing is on a different matrix I'm still digesting (there are 3 pricing models for the above classes of machines), but basically within a family each supersizing costs you double -- extra large is twice large and quadruple is another doubling of that.

    So, which is a good choice? And in running multithreaded applications, would I go with 1 thread per core or 1 per EC2?

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...